Pergolide: Treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of Pergolide versus L-Dopa

Journal of Neural Transmission

Volumn 104, Issue 4-5, 1997, Pages 461-468

  Staedt, J ^a   Wassmuth F ^a   Ziemann, U ^a   Hajak, G ^a   Ruther E ^a   Stoppe, G ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

L dopa; NMS; Nocturnal myoclonus syndrome; Pergolide; PMS; Restless legs syndrome; RLS

Indexed keywords

CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PERGOLIDE MESILATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MYOCLONUS; NAUSEA; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP TIME; SLEEP WAKING CYCLE; SLOW WAVE SLEEP;

AGED; CARBIDOPA; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MYOCLONUS; PERGOLIDE; RESTLESS LEGS SYNDROME; SLEEP; SYNDROME; TREATMENT OUTCOME;

EID: 0030865047     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01277664     Document Type: Article

References (26)

1. Akpinar S (1982) Treatment of restless Legs syndrome with levodopa plus benserazid. Arch Neurol 39: 739
2. Ancoli-Israel S, Kripke DF, Klauber MR, Mason W, Fell R, Kaplan OJ (1991) Periodic limb movements in sleep in community dwelling elderly. Sleep 14: 496-500
3. Brodeur C, Montplaisir J, Goudbout R, Marinier R (1988) Treatment of restless Legs syndrome and periodic movements during sleep with L-dopa. Neurology 38: 1845-1848
4. Brown F, Campbell W, Mitchell PJ, Randall K (1985) Dopamine autoreceptors and the effect of drugs on locomotion and dopamine synthesis. Br J Pharmacol 84: 853-860
5. Coleman RM, Pollack C, Weitzman ED (1980) Periodic movements in sleep (nocturnal myoclonus): relation to sleep-wake disorder. Ann Neurol 8: 416-421
6. Ekbom KA (1945) Restless legs. Acta Med Scand 158 [Suppl]: 1-123
7. Fahn S, Marsden CD, van Woert MH (1986) Definition and classification of myoclonus. In: Fahn S, Marsden CD, van Woert MH (eds) Myoclonus: advances in neurology, vol 43. Raven Press, New York, pp 1-5
8. Guilleminault C, Cetel M, Philip P (1993) Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 43: 445
9. Lugaresi E, Coccagna G, Tassinari CA, Ambrosetto C (1965) Relievi poligrafici sui fenomeni motori nella syndrome delle gambe senze riposo. Riv Neurol 35: 550-561
10. Lugaresi E, Coccagna G, Gambi D, Berti-Ceroni G, Poppi M (1966) A propos de quelques manifestations nocturnes myocloniques (nocturnal myoclonus de Symonds). Rev Neurol 115: 547-555
11. Lugaresi E, Coccagna G, Berti-Ceroni G, Ambrosetto C (1968) Restless legs syndrome and nocturnal myoclonus. In: Gastaut H, Lugaresi E, Berti-Ceroni G, Coccagna G (eds) The abnormalities of sleep in man. Aulo Gaggi Editore, Bologna, pp 285-294
12. Mitler MM, Browman CP, Menn SJ, Gujavarty K, Timms RM (1986) Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 9: 385-392
13. Montplaisir J, Godbout R, Poirier G, Bedard MA (1986) Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol 9: 456-463
14. Montplaisir J, Lorrain D, Godbout R (1991) Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur Neurol 31: 41-43
15. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Brain Information Service/Brain Research Institute, UCLA, Los Angeles
16. Silber MH, Shepard JW, Wisbey JA (1995) The role of pergolide in the management of restless legs syndrome. Sleep Res 24A: 366
17. 2 receptor alterations in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm [Gen Sect] 93: 71-74
18. Staedt J, Stoppe G, Kögler A, Munz DL, Hajak G, Staedt U, Riemann H, Rüther E (1994) Nächtliches Myoklonie-Syndrom (NMS) und Restless-Legs-Syndrom (RLS)-Ubersicht und Fallbeschreibung. Fortschr Neurol Psychiat 62: 88-93
19. Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Munz DL, Emrich D, Rüther E (1995a) Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm [Gen Sect] 99: 187-193
20. Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Munz DL, Emrich D, Rüther E (1995b) Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 245: 8-10
21. Staedt J, Stoppe G, Riemann H, Hajak G, Rüther E, Riederer P (1996) Lamotrigine in the treatment of Nocturnal Myoclonus Syndrome (NMS): two case reports. J Neural Transm 103: 355-361
22. Symonds CP (1953) Nocturnal myoclonus. J Neurol Neurosurg Psychiatry 16: 166-171
23. Trenkwalder C, Stiasny K, Pollmächer Th, Wetter Th, Schwarz J, Kohnen R, Kazenwadel J, Krüger HP, Ramm S, Künzel M, Oertel WH (1995) L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 18: 681-688
24. Waddington JL, O'Boyle KM (1989) Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D1 antagonist. Pharmacol Ther 43: 1-52
25. Walters AS, Hennig WA, Kavey N, Chokroverty S, Gidro-Frank S (1988) A double blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24: 455-458
26. Yarbrough GG, Mcguffin-Clineschmidt J, Singh DK, Haubrich DR, Bendesky RJ, Martin GE (1984) Electrophysiological, biochemical and behavioral assessment of dopamine autoreceptor activation by series of dopamine agonists. Eur J Pharmacol 99: 73-78